ìÑô÷Ѩη¿¡¼ ÝÂ×îÇÑ AspergillusÀÇ MouseíôÐï¿¡ ÓßÇÑ Ü»ê«àõ¿¡ °üÇÑ æÚϼ
Pathogenicity in Mice of Aspergillus Species Identified from Human Trachea
À±º´·¡, ±èÀͼö, ÃÖ¼¼Áø, Àå¸í¿õ, À̹ÌÁ¤,
¼Ò¼Ó »ó¼¼Á¤º¸
À±º´·¡ ( ) - Ãæ³²´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç
±èÀͼö ( ) - Ãæ³²´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç
ÃÖ¼¼Áø ( ) - Ãæ³²´ëÇб³ Àǰú´ëÇÐ ¸¶Ãë°úÇб³½Ç
Àå¸í¿õ ( ) - Ãæ³²´ëÇб³ Àǰú´ëÇÐ ¹Ì»ý¹°Çб³½Ç
À̹ÌÁ¤ ( ) - Ãæ³²´ëÇб³ Àǰú´ëÇÐ º´¸®Çб³½Ç
KMID : 0356919770100030043
Abstract
Attempts were made to investigate the pathogenicity of the aspergillus species by innoculating normal mice intravenously with aspergillus suspension, 10^(5) spores/ml and 5¡¿10^(4) spore/ml concentration and as a comparison group, concentration of hormodendrum suspension 5¡¿10^(4) spore/ml.
The following results were obained.
1) High peak mortality (51.5%) was seen at the 5th and 6th day after innoculation.
2) Cause of death was suspected as infection of the kidney.
3) Aspergillus species(mortality, 94.2%) has shown more pathogenicity than hormodendrum group (mortality 25%).
4) The main pathological changes were: in lung, 63% congestion, 37% inflammation, in liver, 63% congestion, 19% inflammation, in heart, 60% congestion, 26% inflammation, and in kidney, 81% inflammation, 52% congestion.
5) On identification of fungus with PAS stain, there were 9 cases in kidney (25.7%) and 1 case in heart (2.85).
Ű¿öµå
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸